U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07089979) titled 'Effectiveness of Glunovo Real-Time Continuous Glucose Monitoring in Adults With Type 2 Diabetes' on April 09.
Brief Summary: The study aims to evaluate the effectiveness of the novel Real-Time Continuous Glucose Monitoring (RT-CGM) system "Glunovo" in improving glycemic control and patient-reported outcomes in individuals with poorly controlled Type 2 Diabetes (T2D).
Study Start Date: Jan. 01, 2024
Study Type: INTERVENTIONAL
Condition:
Glucose Monitoring, Continuous
Intervention:
DEVICE: Glunovo CGM device
Group 1 (Subjects that will use Glunovo CGM device) will be compared to Group 2 (subject that will use their glucometer)...